-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
Influenza-A-virus-IN-5
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2464415-12-9.gif)
| Category | Influenza Virus |
| CAS | 2464415-12-9 |
| Description | Influenza A virus-IN-5 (Compound 16e) is a potent, orally active anti-influenza A virus (IAV) agent with an IC50 of 1.29 μM. |
Product Information
| Synonyms | Influenza A virus-IN-5|CHEMBL4783111|HY-146359|CS-0498473 |
| Molecular Weight | 397.47 |
| Molecular Formula | C24H23N5O |
| Canonical SMILES | C1CCN(C1)C2=NC3=CC=CC=C3C(=N2)NCC(=O)NC4=CC5=CC=CC=C5C=C4 |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 580 |
| Exact Mass | 397.19026037 |
| Target | Influenza Virus; DNA/RNA Synthesis |
| XLogP3-AA | 5 |
